Response to treatment in a patient with gouty arthritis and tophi evaluated by fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography

J Clin Rheumatol. 2014 Jun;20(4):233-4. doi: 10.1097/RHU.0000000000000111.

Authors

Giorgio Treglia¹, Luca Giovanella, Barbara Muoio, Francesco Bertagna

Affiliation

¹ From the *Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and †School of Medicine, Catholic University of the Sacred Heart, Rome; and ‡Department of Nuclear Medicine, University of Brescia and Spedali Civili of Brescia, Brescia, Italy.

PMID: 24847753
DOI: 10.1097/RHU.0000000000000111

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Arthritis, Gouty / diagnostic imaging*
Arthritis, Gouty / drug therapy
Colchicine / therapeutic use*
Fluorodeoxyglucose F18*
Gout Suppressants / therapeutic use*
Humans
Male
Positron-Emission Tomography / methods*
Radiopharmaceuticals*
Tomography, X-Ray Computed / methods*
Treatment Outcome

Substances

Gout Suppressants
Radiopharmaceuticals
Fluorodeoxyglucose F18
Colchicine